The patient may also experience an abnormally high or abnormally low blood pressure in nephrotic syndrome (DiSalvo et al., 2002; Khan & Falk, 2001). Amyloid protein can limit the ability of the ...

Alzheimer's blood tests show accuracy gaps across populations, raising concerns about reliable diagnosis and healthcare inequality.

This finding is especially interesting because Metformin has already been used safely for many years to treat people with ...

Treatment modalities include liver transplantation for transthyretin-related (ATTR) amyloidosis ... intermediate-dose melphalan and peripheral blood stem-cell transplantation is currently the ...

Alzheimer’s disease is usually associated with old age. But around 5%-10% of all Alzheimer’s cases occur in people under the age of 65. Early-onset Alzheimer’s disease progresses more rapidly and ...

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques ... the dosage to see how gantenerumab might work over a longer time.

However, much work remains to be ... inflammatory responses to amyloid deposits in the brain may vary by race, potentially influencing biomarker levels in the blood and CSF. Hu and his colleagues ...

In a study of biomarkers in Alzheimer’s dementia, plasma p-tau217 had greater agreement with CSF and amyloid-PET biomarker ...